Upload Avatar (500 x 500)
Liu Libo
Life Science
China Medical University
Liaoning
Language: Chinese, English
Blood-Tumor Barrier
Glioma
Molecular Therapy
Regulation
Angiogenesis
Vegfr2
P53
Rbm4
Emap-Ii
Mir-429
Areas of Focus
- Regulation of Blood-Tumor Barrier
- Molecular Targeted Therapy of Glioma
Publications
- AMG232 inhibits the angiogenesis in glioma through p53/RBM4/VEGFR2 pathway, Xiao Y, Ma T, Li ML, Ning H, Liu LB*, 2023
- MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5, Chen LY, Xue YX, Zheng J, Liu XB, Liu J, Chen JJ, Li Z, Xi Z, Teng H, Wang P, Liu LB*, Liu YH*, 2018
- Bradykinin increased the permeability of BTB via NOS/NO/ZONAB-mediating down-regulation of claudin-5 and occludin, Liu LB, Liu XB, Ma J, et al., 2015
- Effects of Insulin Combined with Idebenone on the Blood-Brain Barrier Permeability in Diabetic Rats, Sun YN, Liu LB(co-first author), Xue YX, Wang P, 2015
Awards
- Liaoning Province Science and Technology Award Second Prize (2014): Regulation of Blood-Tumor Barrier Opening and Molecular Targeted Therapy of Glioma
- Liaoning Medical Science and Technology Award First Prize (2014): Regulation of Blood-Tumor Barrier Opening and Molecular Targeted Therapy of Glioma
- Shenyang Science and Technology Progress Award First Prize (2014): Regulation of Blood-Tumor Barrier Opening and Molecular Targeted Therapy of Glioma
